The proposed renewal is for a continuation of the Biology of Infectious Diseases Training Program to train physician-scientists in infectious diseases-related translational research, both clinical and laboratory-based. The program draws on the laboratory and clinical research skills and resources of a broad group of faculty addressing questions directly relevant to infectious diseases. Funding is requested for four postdoctoral trainees per year, primarily MDs or MD/PhDs, recruited the UCSF Infectious Diseases Fellowship Program, but also PhD postdoctoral trainees from research faculty laboratories. We continue to improve our efforts to recruit underrepresented minorities and women into the program. The main program is a hands-on research experience under the close supervision of a research mentor and a career development committee selected on the basis of the research interests and goals of the trainee. Research may be at the molecular, cellular, whole animal, clinical, or population levels. Educational and training opportunities have been created to prepare individuals for research and leadership positions in academic medicine, public health, or industry in the areas of epidemiology, public health, global health, HIV/AIDS, genomics, antimicrobial resistance, microbial pathogenesis and host response, and immunology. The educational program provides for special courses, small group conferences, research conferences and seminars, coursework in immunology, microbial pathogenesis, biostatistics, epidemiology, study design, scientific writing, and ethics of scientific conduct. Emphasis is placed on personal instruction specifically designed for individual trainees and on multidiscipline interactions. The quality and effectiveness of the program is measured by the success of our trainees in 1) completion of fellowship training, 2) the number and quality of publications in peer-reviewed journals and research presentations, 3) obtaining research funding (e.g., independent research awards, K-awards or equivalent career-development awards, R01-level or equivalent awards), and 4) attainment of a research-oriented career as medical school faculty, in industry, or in the public health sector.
Infectious diseases are the third most common cause of death in the United States, despite availability of antibiotics, vaccines, and high standards of public health and the leading cause of death worldwide. Our program supports the training of young scientists that will address high impact research questions aimed at improving our knowledge, treatment, control, and prevention of infectious diseases.
|Solomon, Marc M; Mayer, Kenneth H; Glidden, David V et al. (2015) Reply to Boyd et al. Clin Infect Dis 60:327|
|Solomon, Marc M; Lama, Javier R; Glidden, David V et al. (2014) Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS 28:851-9|
|Solomon, Marc M; Mayer, Kenneth H; Glidden, David V et al. (2014) Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial. Clin Infect Dis 59:1020-6|
|Solomon, Marc M; Mayer, Kenneth H (2014) Evolution of the syphilis epidemic among men who have sex with men. Sex Health :|
|Visconti, Adam J; Biddle, Joshua; Solomon, Marc (2014) Follow-up imaging for vertebral osteomyelitis: a teachable moment. JAMA Intern Med 174:184|
|Ljubojevic, Senka; Radulovic, Snjezana; Leitinger, Gerd et al. (2014) Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure. Circulation 130:244-55|
|Nussbaum, Jesse C; Van Dyken, Steven J; von Moltke, Jakob et al. (2013) Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502:245-8|
|Vijayan, Tara; Klausner, Jeffrey D (2013) Integrating clinical services for HIV, tuberculosis, and cryptococcal disease in the developing world: a step forward with 2 novel diagnostic tests. J Int Assoc Provid AIDS Care 12:301-5|
|Babik, Jennifer M; Cohan, Deborah; Monto, Alexander et al. (2011) The human fetal immune response to hepatitis C virus exposure in utero. J Infect Dis 203:196-206|
|Rosenberg, Oren S; Dovey, Cole; Tempesta, Michael et al. (2011) EspR, a key regulator of Mycobacterium tuberculosis virulence, adopts a unique dimeric structure among helix-turn-helix proteins. Proc Natl Acad Sci U S A 108:13450-5|
Showing the most recent 10 out of 17 publications